ofloxacin has been researched along with MODS in 5 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "pneumoniae serotype K1, complicated by septic shock and multiple organ dysfunction." | 1.35 | Rapidly fatal bacteremic pneumonia caused by Klebsiella pneumoniae with K1 hypermucoviscosity phenotype in a previously healthy young man receiving levofloxacin treatment. ( Chi, CL; Chuang, TY; Hsueh, PR; Lee, SW; Lin, CJ; Lin, TL; Liu, AY; Wang, JT, 2009) |
| " In addition to standard pharmacokinetic parameters, the total dialysate concentration of both drugs was measured using a technically simple single-pass batch dialysis system for EDD." | 1.33 | Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. ( Czock, D; de Groot, K; Fliser, D; Hafer, C; Haller, H; Hüsig-Linde, C; Keller, F; Kielstein, JT; Kuse, E; Langhoff, A; Schöpke, T; Swoboda, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eberlein, M | 1 |
| Chahla, MF | 1 |
| Baierlein, SA | 1 |
| Mahon, RT | 1 |
| Chuang, TY | 1 |
| Lin, CJ | 1 |
| Chi, CL | 1 |
| Liu, AY | 1 |
| Lee, SW | 1 |
| Lin, TL | 1 |
| Wang, JT | 1 |
| Hsueh, PR | 1 |
| Guettrot-Imbert, G | 1 |
| Letranchant, L | 1 |
| Gallot, D | 1 |
| Romaszko, C | 1 |
| Laurichesse, H | 1 |
| Czock, D | 1 |
| Hüsig-Linde, C | 1 |
| Langhoff, A | 1 |
| Schöpke, T | 1 |
| Hafer, C | 1 |
| de Groot, K | 1 |
| Swoboda, S | 1 |
| Kuse, E | 1 |
| Haller, H | 1 |
| Fliser, D | 1 |
| Keller, F | 1 |
| Kielstein, JT | 1 |
| Cracco, C | 1 |
| Delafosse, C | 1 |
| Baril, L | 1 |
| Lefort, Y | 1 |
| Morelot, C | 1 |
| Derenne, JP | 1 |
| Bricaire, F | 1 |
| Similowski, T | 1 |
5 other studies available for ofloxacin and MODS
| Article | Year |
|---|---|
A fall in Ghana.
Topics: Accidental Falls; Adult; Anti-Bacterial Agents; Back Pain; Bacteremia; Diagnosis, Differential; Ghan | 2009 |
Rapidly fatal bacteremic pneumonia caused by Klebsiella pneumoniae with K1 hypermucoviscosity phenotype in a previously healthy young man receiving levofloxacin treatment.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacteremia; Bacterial Capsules; Bacterial Typing Techniq | 2009 |
[Multiorgan failure due to gonococcal peritonitis in an HIV-HCV co-infected female patient].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ascites; Bacteremia; Carcinoma, Hepatocellular | 2004 |
Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Anuria; Aza Compounds; Critical Care; Criti | 2006 |
Multiple organ failure complicating probable scrub typhus.
Topics: Adult; Anti-Infective Agents; Cefotaxime; Cephalosporins; Female; Humans; Infant, Newborn; Multiple | 2000 |